Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal
unknown
📅 Published: 2025-10-29 20:45
📰 Source: Yahoo
📝 Words: 55
📝 Article Content
The drugmaker Eli Lilly reports its third-quarter results early Thursday, as questions loom about what kind of deal it will reach with the Trump administration over the price of its weight-loss drug. Lilly shares are up about 5% this year. Lilly appears to have triumphed over Novo Nordisk in the battle for the weight-loss market.
📄 Summary
The drugmaker Eli Lilly reports its third-quarter results early Thursday, as questions loom about what kind of deal it will reach with the Trump administration over the price of its weight-loss drug. Lilly shares are up about 5% this year. Lilly appears to have triumphed over Novo Nordisk in the battle for the weight-loss market.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2025-10-30 17:36:09
Updated At:
2025-10-30 17:36:09
Scraping Job ID:
N/A
Stock Mentions:
LLY - Eli Lilly and Company
Relevance: N/A